Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Semin Oncol. 2010 Oct;37(5):473–484. doi: 10.1053/j.seminoncol.2010.09.001

Figure 3. ALC≥1000 correlates with clinical benefit.

Figure 3

In a study by Ku et al.58, all of the patients with clinical benefit (CR+PR+SD) at 24 weeks had an ALC ≥1000 at week 7 of the study. Conversely, none of the patients with an ALC<1000 at week 7 had clinical benefit. The entire study includes a total of 51 patients, 41 patients were evaluable for ALC at week 7 and clinical benefit at week 24.